Pacific Biosciences of California, Inc. Share Price Deutsche Boerse AG
Equities
P09
US69404D1081
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.556 EUR | +0.34% | +9.06% | -82.49% |
Sales 2024 * | 193M 181M 15.41B | Sales 2025 * | 285M 266M 22.72B | Capitalization | 436M 407M 34.77B |
---|---|---|---|---|---|
Net income 2024 * | -283M -265M -22.58B | Net income 2025 * | -235M -220M -18.75B | EV / Sales 2024 * | 4.49 x |
Net Debt 2024 * | 432M 404M 34.45B | Net Debt 2025 * | 502M 469M 40.03B | EV / Sales 2025 * | 3.29 x |
P/E ratio 2024 * |
-1.54
x | P/E ratio 2025 * |
-1.9
x | Employees | 796 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.18% |
Latest transcript on Pacific Biosciences of California, Inc.
1 day | +0.34% | ||
1 week | +9.06% | ||
Current month | -53.95% | ||
1 month | -53.95% | ||
3 months | -75.71% | ||
6 months | -79.51% | ||
Current year | -82.49% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Turner
FOU | Founder | 56 | 13/07/00 |
Christian Henry
CEO | Chief Executive Officer | 56 | 31/07/18 |
Susan Kim
DFI | Director of Finance/CFO | 48 | 27/09/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Milligan
CHM | Chairman | 63 | 17/07/13 |
Marshall Mohr
BRD | Director/Board Member | 67 | 17/01/12 |
Christian Henry
CEO | Chief Executive Officer | 56 | 31/07/18 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 1.551 | +15.51% | 8 873 |
26/04/24 | 1.266 | +1.07% | 21,115 |
25/04/24 | 1.252 | -16.07% | 8,826 |
24/04/24 | 1.492 | +2.91% | 7,500 |
23/04/24 | 1.45 | +1.95% | 750 |
Delayed Quote Deutsche Boerse AG, April 29, 2024 at 04:16 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.69% | 220B | |
+6.69% | 183B | |
+10.90% | 133B | |
+25.41% | 107B | |
+0.27% | 63.05B | |
+12.72% | 51.74B | |
+3.96% | 50.47B | |
+0.40% | 40.91B | |
+15.03% | 40.59B |
- Stock Market
- Equities
- PACB Stock
- P09 Stock